Maximum quantity allowed is 999
Please select the quantity
CAS RN: 13311-84-7 | Product Number: F0663
Flutamide
×
![]()
×
Purity: >98.0%(GC)
Synonyms:
- 4'-Nitro-3'-(trifluoromethyl)isobutyranilide
- 2-Methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propionamide
Product Documents:
| Size | Unit Price | Same Day | 2-3 Business Days |
|---|---|---|---|
| 5G |
$43.00
|
6 | ≥40 |
| 25G |
$128.00
|
18 | Contact Us |
* Please contact our distributors or
TCI
to order our products. The above prices do not include freight cost, customs, and other charges to the destination.
* The storage conditions are subject to change without notice.
| Product Number | F0663 |
| Purity / Analysis Method | >98.0%(GC) |
| Molecular Formula / Molecular Weight | C__1__1H__1__1F__3N__2O__3 = 276.22 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature | Room Temperature (Recommended in a cool and dark place, <15°C) |
| Condition to Avoid | Light Sensitive |
| CAS RN | 13311-84-7 |
| Reaxys Registry Number | 2157663 |
| PubChem Substance ID | 87560202 |
| Merck Index (14) | 4208 |
| MDL Number | MFCD00072009 |
Specifications
| Appearance | White to Light yellow to Green powder to crystal |
| Purity(GC) | min. 98.0 % |
| Melting point | 110.0 to 114.0 °C |
Properties (reference)
| Melting Point | 112 °C |
| Solubility in water | Insoluble |
| Solubility (soluble in) | Chloroform, Ether |
GHS
| Pictogram |
|
| Signal Word | Danger |
| Hazard Statements | H302 : Harmful if swallowed. H315 : Causes skin irritation. H319 : Causes serious eye irritation. H361 : Suspected of damaging fertility or the unborn child. H370 : Causes damage to organs. |
| Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P260 : Do not breathe dust/ fume/ gas/ mist/ vapors/ spray. P270 : Do not eat, drink or smoke when using this product. P202 : Do not handle until all safety precautions have been read and understood. P201 : Obtain special instructions before use. P264 : Wash skin thoroughly after handling. P280 : Wear protective gloves/ protective clothing/ eye protection/ face protection. P302 + P352 : IF ON SKIN: Wash with plenty of water. P337 + P313 : If eye irritation persists: Get medical advice/ attention. P305 + P351 + P338 : IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P308 + P311 : IF exposed or concerned: Call a POISON CENTER/doctor. P362 + P364 : Take off contaminated clothing and wash it before reuse. P332 + P313 : If skin irritation occurs: Get medical advice/ attention. P301 + P312 + P330 : IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. Rinse mouth. P405 : Store locked up. |
Related Laws:
| RTECS# | UG5700000 |
Transport Information:
| H.S.code* | 2924.29-000 |
Application
Flutamide: A Non-Steroidal Androgen Receptor Antagonist
Flutamide (SCH 13521) and bicalutamide [B3206] are non-steroidal androgen receptor antagonists with antiandrogenic activity. Testosterone [T0027], the most important androgen, converted to 5α-dihydrotestosterone (DHT) [A0462] by 5α-reductase type 2 which reduces the 4,5-double bond of testosterone in prostate cells. DHT has two or three times greater androgen receptor (AR) affinity than testosterone. Upon DHT binding, the AR undergoes a conformational change and releases heat shock proteins (HSPs), resulting in mRNA expression and prostate cell proliferation. Flutamide is rapidly metabolized by hydroxylation of the side chain to primary active form 2-hydroxyflutamide [H1600]. Subsequently, 2-hydroxyflutamide acts as a potent and highly selective competitive antagonist of the AR, blocks the conversion of testosterone to DHT, and inhibits the proliferation of prostate cells. Flutamide and bicalutamide are used for the treatment of prostate cancer and other androgen-dependent conditions. (The product is for research purpose only.)
References
- Biological profile of a nonsteroidal antiandrogen, SCH 13521 (4'-nitro-3'-trifluoromethylisobutyranilide)
- Characteristics of interaction of the antiandrogen flutamide with the androgen receptor in various target tissues
- Mechanism of action and pure antiandrogenic properties of flutamide
- Selection for androgen receptor mutations in prostate cancers treated with androgen antagonist
- Flutamide. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in advanced prostatic cancer
- Flutamide. A review of methods of preparation, physical properties, stability, metabolism and pharmacokinetics and methods for the detection of flutamide
PubMed Literature
Articles/Brochures
TCIMAIL
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.